CHARLES SIMONE II was named medical director of the Maryland Proton Treatment Center, effective in November. Simone will help define and implement processes ensuring that MPTC is integrated into the radiation oncology program and the University of Maryland Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center/System and the university’s school of medicine. He will...
The Biden administration has left NIH in a weakened state, intensifying politicization of science on Capitol Hill and eroding the bipartisan support the government’s premier biomedical research agency has traditionally enjoyed.
